PMD31 Cost-Effectiveness Analysis of EGFR Testing and Gefitinib for Non-Small-Cell Lung Cancer (NSCLC) in Japan
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.371
https://www.valueinhealthjournal.com/article/S1098-3015(12)00436-6/fulltext
Title :
PMD31 Cost-Effectiveness Analysis of EGFR Testing and Gefitinib for Non-Small-Cell Lung Cancer (NSCLC) in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00436-6&doi=10.1016/j.jval.2012.03.371
First page :
A67
Section Title :
Medical Device/Diagnostics
Open access? :
No
Section Order :
1154